Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | GeneDx Holdings Corp. | Ryan Jason
(Director) |
S | Class A Common Stock | D | 47000 | $68.36 - $72.26 | $3,316,876 |
| 2024-11-19 | GeneDx Holdings Corp. | Ryan Jason
(Director) |
G | Class A Common Stock | D | 141356 | $0.00 - $0.00 | $0 |
| 2024-11-15 | GeneDx Holdings Corp. | MOUNT SINAI HEALT...
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 147141 | $69.78 - $70.78 | $10,393,722 |
| 2024-11-15 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
S | Class A Common Stock | D | 45415 | $66.60 - $74.34 | $3,197,679 |
| 2024-10-29 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 274 | $66.60 - $66.60 | $18,248 |
| 2024-10-29 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 753 | $0.00 - $0.00 | $0 |
| 2024-10-29 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
S | Class A Common Stock | D | 2154 | $66.60 - $66.60 | $143,456 |
| 2024-10-29 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
M | Class A Common Stock | A | 3874 | $0.00 - $0.00 | $0 |
| 2024-09-16 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
S | Class A Common Stock | D | 10501 | $37.59 - $37.59 | $394,732 |
| 2024-09-16 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
M | Class A Common Stock | A | 18750 | $0.00 - $0.00 | $0 |
| 2024-09-16 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 2635 | $37.59 - $37.59 | $99,049 |
| 2024-09-16 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 7197 | $0.00 - $0.00 | $0 |
| 2024-09-09 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 895 | $33.33 - $33.33 | $29,830 |
| 2024-09-09 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 2462 | $0.00 - $0.00 | $0 |
| 2024-09-09 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
S | Class A Common Stock | D | 3639 | $33.33 - $33.33 | $121,287 |
| 2024-09-09 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
M | Class A Common Stock | A | 6546 | $0.00 - $0.00 | $0 |
| 2024-08-01 | GeneDx Holdings Corp. | Casdin Eli
(Director) |
J | Class A Common Stock | A | 413655 | $32.25 - $32.25 | $13,340,373 |
| 2024-07-29 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 274 | $33.54 - $33.54 | $9,189 |
| 2024-07-29 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 753 | $0.00 - $0.00 | $0 |
| 2024-07-24 | GeneDx Holdings Corp. | OPKO HEALTH, INC.
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 135000 | $33.72 - $33.85 | $4,560,363 |
| 2024-07-19 | GeneDx Holdings Corp. | OPKO HEALTH, INC.
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 150000 | $32.29 - $33.46 | $4,946,935 |
| 2024-07-17 | GeneDx Holdings Corp. | OPKO HEALTH, INC.
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 25000 | $32.93 - $32.93 | $823,187 |
| 2024-07-05 | GeneDx Holdings Corp. | OPKO HEALTH, INC.
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 36118 | $28.24 - $28.24 | $1,020,015 |
| 2024-07-01 | GeneDx Holdings Corp. | OPKO HEALTH, INC.
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 89082 | $26.63 - $29.12 | $2,457,286 |
| 2024-06-20 | GeneDx Holdings Corp. | Casdin Eli
(Director) |
M | Class A Common Stock | A | 5828 | $0.00 - $0.00 | $0 |
| 2024-06-20 | GeneDx Holdings Corp. | Leproust Emily M.
(Director) |
M | Class A Common Stock | A | 5828 | $0.00 - $0.00 | $0 |
| 2024-06-20 | GeneDx Holdings Corp. | PFENNIGER RICHARD...
(Director) |
M | Class A Common Stock | A | 5828 | $0.00 - $0.00 | $0 |
| 2024-06-20 | GeneDx Holdings Corp. | RUCH JOSHUA
(Director) |
M | Class A Common Stock | A | 5828 | $0.00 - $0.00 | $0 |
| 2024-06-20 | GeneDx Holdings Corp. | Meister Keith A.
(Director) |
M | Class A Common Stock | A | 5828 | $0.00 - $0.00 | $0 |
| 2024-06-17 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
S | Class A Common Stock | D | 2646 | $28.31 - $28.31 | $74,908 |
| 2024-06-16 | GeneDx Holdings Corp. | Feeley Kevin
(CHIEF FINANCIAL OFFICER) |
M | Class A Common Stock | A | 7197 | $0.00 - $0.00 | $0 |
| 2024-06-17 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
S | Class A Common Stock | D | 7683 | $28.31 - $28.31 | $217,505 |
| 2024-06-16 | GeneDx Holdings Corp. | Stueland Katherine
(Chief Executive Officer) |
M | Class A Common Stock | A | 18750 | $0.00 - $0.00 | $0 |
| 2024-06-03 | GeneDx Holdings Corp. | Casdin Partners F...
(Director) |
P | Class A Common Stock | A | 130000 | $20.82 - $22.52 | $2,757,117 |
| 2024-05-29 | GeneDx Holdings Corp. | Casdin Partners F...
(Director) |
P | Class A Common Stock | A | 40000 | $21.07 - $21.07 | $842,604 |
| 2024-05-23 | GeneDx Holdings Corp. | Casdin Partners F...
(AtLeastTenPercentOwner) |
P | Class A Common Stock | A | 170000 | $19.59 - $20.61 | $3,424,988 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |